Literature DB >> 20731909

[hnRNP K expression and its clinical significance in human lung cancer tissues.].

Yan Chen1, Weimin Li, Shangfu Zhang.   

Abstract

BACKGROUND: There is no any specific criterion in early diagnosis of lung cancer yet. The aim of this study is to determine hnRNP K expression in lung cancer tissues and normal lung tissues and to provide data for the diagnosis and treatment of lung cancer.
METHODS: The expression of hnRNP K was studied by using the SP method of immunohistochemistry in lung tissue samples of 70 cases of lung cancer and 27 cases of control groups.
RESULTS: The positive rate of hnRNP K was 64.9% (76/117) in lung cancer tissues , which was significantly higher than that in control group (33.3%, 9/27) (P <0.001) . hnRNP K was localized in the cytoplasm and/or nucleus. Three subtypes of lung cancer all showed positive staining of hnRNP K protein. The positive rate of hnRNP Kwas 73.7% (14/19) in SCLC and 54.9% (28/51) in NSCLC (P >0.05) .
CONCLUSIONS: hnRNP K can highly express in lung cancer tissues, but it does not correlate with histological classification of lung cancer.

Entities:  

Year:  2008        PMID: 20731909     DOI: 10.3779/j.issn.1009-3419.2008.02.017

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  3 in total

1.  Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis.

Authors:  Ran Gao; Yue Yu; Atsushi Inoue; Nashi Widodo; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

2.  Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.

Authors:  Mengyuan Li; Xingjiu Yang; Guoxin Zhang; Le Wang; Ziwei Zhu; Wenlong Zhang; Hao Huang; Ran Gao
Journal:  Thorac Cancer       Date:  2022-03-29       Impact factor: 3.223

3.  Downregulation of HNRNPK in human cancer cells inhibits lung metastasis.

Authors:  Mengyuan Li; Wenlong Zhang; Xingjiu Yang; Hongfei Liu; Lin Cao; Weisha Li; Le Wang; Guoxin Zhang; Ran Gao
Journal:  Animal Model Exp Med       Date:  2019-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.